Evidence map›Paper›PMID 21542061›Full record

SynthesisHuman mutation2011

ACTN3 genotype, athletic status, and life course physical capability: meta-analysis of the published literature and findings from nine studies.

Tamuno Alfred, Yoav Ben-Shlomo, Rachel Cooper, Rebecca Hardy, Cyrus Cooper, Ian J Deary, David Gunnell, Sarah E Harris, Meena Kumari, Richard M Martin and 9 more

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in Human mutation, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 7 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 7 syntheses or guidelines pooled it, 114 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. The Effect of ACTN3 Gene Doping on Skeletal Muscle Performance.American journal of human genetics · 2018
    Pooled it
  7. Pooled it
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Association of theGenes · 2023
    Article
  13. Association ofGenes · 2023
    Article
  14. Article
  15. Article
  16. The association ofBiology of sport · 2022
    Article
  17. Association of theGenes · 2022
    Article
  18. Article
  19. The ACE and ACTN3 polymorphisms in female soccer athletes.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2021
    Article
  20. Genetic test for the personalization of sport training.Acta bio-medica : Atenei Parmensis · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 2 countries.

Tamuno AlfredSchool of Social and Community Medicine, University of Bristol, Bristol, United Kingdom. tamuno.alfred@bristol.ac.uk
Yoav Ben-Shlomo
Rachel Cooper
Rebecca Hardy
Cyrus Cooper
Ian J Deary
David Gunnell
Sarah E Harris
Meena Kumari
Richard M Martin
Colin N Moran
Yannis P Pitsiladis
Susan M Ring
Avan Aihie Sayer
George Davey Smith
John M Starr
Diana Kuh
Ian N M Day
HALCyon study team
University of Bristol · GBAlphabio · FRMRC Unit for Lifelong Health and Ageing · GBSouthampton General Hospital · GBUniversity of Oxford · GBUniversity of Ulster · GB

Funding

Project-001R01AG017644 · NIA · UNIVERSITY OF LONDON INST OF NEUROLOGY · PI Andrew Steptoe · 2000 to 2026
$56.2M
Socio-economic status and heterogeneity in agingR01AG013196 · NIA · UNIVERSITY OF LONDON INST OF NEUROLOGY · PI MARMOT, MICHAEL G, SINGH-MANOUX, ARCHANA · 1996 to 2013
$3.5M
Menopause: Meaning and Experience in Oaxaca, MexicoR03AG017655 · NIA · UNIVERSITY OF IOWA · PI RAMIREZ, MICHELLE · 2001 to 2002
$31k
Arthritis Research UKBiotechnology and Biological Sciences Research Council 15/SAG09977Biotechnology and Biological Sciences Research Council BB/F019394/1British Heart FoundationDepartment of Health 74882Medical Research Council 17/D17566Medical Research Council G0600705Medical Research Council MC_U123092724Medical Research Council MC_UP_A620_1014Medical Research Council MC_UP_A620_1015NIA NIH HHS AG1765506S1NIA NIH HHS R01 AG013196NIA NIH HHS R01 AG017644Wellcome Trust 076467Wellcome Trust 092731Wellcome Trust GR068468MA
6 · The paper itself

Abstract

The ACTN3 R577X (rs1815739) genotype has been associated with athletic status and muscle phenotypes, although not consistently. Our objective was to conduct a meta-analysis of the published literature on athletic status and investigate its associations with physical capability in several new population-based studies. Relevant data were extracted from studies in the literature, comparing genotype frequencies between controls and sprint/power and endurance athletes. For life course physical capability, data were used from two studies of adolescents and seven studies in the Healthy Ageing across the Life Course (HALCyon) collaborative research program, involving individuals aged between 53 and 90+ years. We found evidence from the published literature to support the hypothesis that in Europeans the RR genotype is more common among sprint/power athletes compared with their controls. There is currently no evidence that the X allele is advantageous to endurance athleticism. We found no association between R577X and grip strength (P = 0.09, n = 7,672 in males; P = 0.90, n = 7,839 in females), standing balance, timed get up and go, or chair rises in our studies of physical capability. The ACTN3 R577X genotype is associated with sprint/power athletic status in Europeans, but does not appear to be associated with objective measures of physical capability in the general population.

Indexed as

AthletesActininAdolescentAdultAgedAged, 80 and overChildFemaleGenetic Association StudiesGenotypeHumansMaleMiddle AgedPhysical EnduranceYoung AdultActininACTN3 protein, human

Identifiers

PMID21542061
PMCPMC3174315
OpenAlexW2136683218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.